COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET
可卡因对脑血流的影响--OXYGEN 15 PET
基本信息
- 批准号:6245468
- 负责人:
- 金额:$ 2.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-03-05 至 1997-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cocaine is a commonly abused euphoriant with strong reinforcing effects.
Animal data have shown that the reinforcing properties are related to
cocaine's activity on the dopamine system including the transporter. We
designed two Positron Emission Tomography studies (a) to investigate
cocaine's activity on dopamine release in humans and (b) on regional
cerebral blood flow.
In study one, 11 male subjects were injected within [11C]-Raclopride, a
positron-emitting dopamine D2 antagonist. 0 to 10 minutes after the
raclopride injection subjects were injected with either saline (baseline
scan) or with 48mg of cocaine hydrochloride (drug scan). Time - Activity
curves (TAC) were obtained for both conditions in putamen and cerebellum.
In study two, three subjects were injected with 0 15 water 30 to 180
seconds after cocaine injection.
All subjects reported subjective euphoriant effects on Visual Analog
Scales. The area under the TAC (corrected for the amount of injected dose
of radioactivity) was 251.0 + 39.1 in the cocaine condition (t=6.7,
p<0.0001, df=10). In study two, global cerebral blood flow was reduced 27
+ 9% using in three subjects. Maximal decreases were seen 60 seconds after
cocaine injection.
We demonstrated that doses of cocaine similar to typical "street doses"
demonstrated significant displacement of a radiolabelled dopamine D2
receptor antagonist. This finding seems consistent with the dopamine
hypothesis of cocaine's actions and is of potential relevance in the
search for pharmacological treatments of cocaine abuse. Furthermore we
replicated the finding of other studies, that cocaine reduces global blood
flow acutely.
可卡因是一种常被滥用的兴奋剂,具有很强的强化作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GODFREY D PEARLSON其他文献
GODFREY D PEARLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GODFREY D PEARLSON', 18)}}的其他基金
3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
3/5 生物标志物/生物型,早期精神病课程和专业服务 (BICEPS)
- 批准号:
10683286 - 财政年份:2022
- 资助金额:
$ 2.23万 - 项目类别:
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
B-SNIP Biotype-1 (CLOZAPINE) 中氯氮平的选择性抗精神病反应为 3/5
- 批准号:
10396432 - 财政年份:2021
- 资助金额:
$ 2.23万 - 项目类别:
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
B-SNIP Biotype-1 (CLOZAPINE) 中氯氮平的选择性抗精神病反应为 3/5
- 批准号:
10613491 - 财政年份:2021
- 资助金额:
$ 2.23万 - 项目类别:
Neuroimaging predictors of bariatric surgical outcomes
减肥手术结果的神经影像预测因素
- 批准号:
10180948 - 财政年份:2018
- 资助金额:
$ 2.23万 - 项目类别:
Neuroimaging predictors of bariatric surgical outcomes
减肥手术结果的神经影像预测因素
- 批准号:
10430196 - 财政年份:2018
- 资助金额:
$ 2.23万 - 项目类别:
Neuroimaging predictors of bariatric surgical outcomes
减肥手术结果的神经影像预测因素
- 批准号:
9981729 - 财政年份:2018
- 资助金额:
$ 2.23万 - 项目类别:
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)
3/4-精神病
- 批准号:
8504331 - 财政年份:2013
- 资助金额:
$ 2.23万 - 项目类别:
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)
3/4-精神病
- 批准号:
8917630 - 财政年份:2013
- 资助金额:
$ 2.23万 - 项目类别:
相似海外基金
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105357 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105363 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2116943 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2695815 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2837847 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105362 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2012861 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105360 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2116945 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105365 - 财政年份:1986
- 资助金额:
$ 2.23万 - 项目类别:














{{item.name}}会员




